Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2
|
作者：
Song, Jiho [1 ]
Lee, Jung Wook [1 ]
Chung, Shin Hyuck [1 ]
Wenas, Michelle A. [1 ]
Min, Kyung Hoon [1 ]
机构：
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;
D O I：
10.1002/bkcs.11278
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1255 / 1256
页数：2
相关论文
共 50 条
  • [1] Structure-activity relationships of pyrazine-based CK2 inhibitors: Synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines
    Suzuki, Yarnato
    Cluzeau, Jerome
    Hara, Takafumi
    Hirasawa, Akira
    Tsujimoto, Gozoh
    Oishi, Shinya
    Ohno, Hiroaki
    Fujii, Nobutaka
    ARCHIV DER PHARMAZIE, 2008, 341 (09) : 554 - 561
  • [2] New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
    Mostafa, Yaser A.
    Assoud, Jalil Abdeljalil
    Desoky, Ahmed Y.
    Mohamady, Samy
    Mohamed, Nesma M.
    Salem, Ola I. A.
    Almarhoon, Zainab M.
    Braese, Stefan
    Youssif, Bahaa G. M.
    FRONTIERS IN CHEMISTRY, 2024, 12
  • [3] Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERα/VEGFR-2 ligands with anti-breast cancer activity
    Luo, Guoshun
    Tang, Zhichao
    Lao, Kejing
    Li, Xinyu
    You, Qidong
    Xiang, Hua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 783 - 795
  • [4] Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library
    Zhang, Q
    Liu, Y
    Gao, F
    Ding, Q
    Cho, C
    Hur, W
    Jin, YH
    Uno, T
    Joazeiro, CAP
    Gray, N
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (07) : 2182 - 2183
  • [5] Discovery and structure-activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2
    Fuchi, Nobuhiro
    Iura, Yosuke
    Kaneko, Hiroaki
    Nitta, Aiko
    Suyama, Kazuharu
    Ueda, Hiroshi
    Yamaguchi, Shinichi
    Nishimura, Kazumi
    Fujii, Shigeo
    Sekiya, Yumiko
    Yamada, Masateru
    Takahashi, Toshiya
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4358 - 4361
  • [6] Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds
    Verma, Meenakshi
    Sarfraz, Aqib
    Hasan, Inamul
    Vasudev, Prema Gauri
    Khan, Feroz
    MEDICINAL CHEMISTRY, 2024, 20 (06) : 646 - 661
  • [7] A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
    Yousefbeyk, Fatemeh
    Ghasemi, Saeed
    PHARMACEUTICAL SCIENCES, 2025, 31 (01) : 43 - 64
  • [8] SULFANILAMIDOPYRIMIDINES .2. 4-SULFANILAMIDOPYRIMIDINES AND CERTAIN 4,6-DISUBSTITUTED PYRIMIDINES
    TAFT, WE
    SHEPHERD, RG
    JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1962, 5 (06): : 1335 - &
  • [9] Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening
    Usui, Taikou
    Ban, Hyun Seung
    Kawada, Junpei
    Hirokawa, Takatsugu
    Nakamura, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 285 - 288
  • [10] Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors
    Pannala, Madhavi
    Kher, Sunil
    Wilson, Norma
    Gaudette, John
    Sircar, Ila
    Zhang, Shao-Hul
    Bakhirev, Alexei
    Yang, Guang
    Yuen, Phoebe
    Gorcsan, Frank
    Sakurai, Naoki
    Barbosa, Miguel
    Cheng, Jie-Fei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5978 - 5982
12345